Table of Contents

• 1.   Market Introduction
  •   1. Objectives of the Study
      2. Market Definition
      3. Market Scope
       3.1 . Years Considered for the Study
       3.2 . Market Covered
      4. Currency
      5. Limitations
      6. Stakeholders
    
• 2.   Research Methodology
  •   1. Research Data
       1.1 . Secondary Data
        1.1.1 . Key Data from Secondary Sources
       1.2 . Primary Data
        1.2.1. Key Data from Primary Sources
      2. Market Size Estimation
      3. Market Breakdown and Data Triangulation
      4. Assumptions for the Study
    
• 3.   Executive Summary
  •   1. Market Outlook
      2. Segment Outlook
      3. Competitive Insights
    
• 4.   Global Clinical Trial Materials and Supplies Market Variables, Trends and Scope

  •   1. Market Lineage Outlook
      2. Penetration and Growth Prospect Mapping
      3. Industry Value Chain Analysis
      4. Cost Analysis Breakdown
      5. Technology Overview
      6. Regulatory Framework
       6.1. Reimbursement Framework
       6.2. Standards and Compliances

• 5.   Market Overview
  •   1. Market Dynamics
       1.1. Market Driver Analysis
        1.1.1. Increasing focus of Clinical Trial Materials and Supplies Companies on Brand Protection
        1.1.2. Untapped Opportunities in Emerging Regions
       1.2. Market Restraint Analysis
        1.2.1. High Cost Associated with Implementation of Predictive Analysis
       1.3. Industry Challenges
        1.3.1. Presence of Ambiguous Regulatory Framework
    
• 6.   Global Clinical Trial Materials and Supplies Market Analysis Tools
  •   1. Industry Analysis - Porter’s
       1.1. Supplier Power
       1.2. Buyer Power
       1.3. Substitution Threat
       1.4. Threat from New Entrants
       1.5. Competitive Rivalry
      2. Pestel Analysis
       2.1. Political Landscape
       2.2. Environmental Landscape
       2.3. Social Landscape
       2.4. Technology Landscape
       2.5. Legal Landscape
      3. Major Deals And Strategic Alliances Analysis
       3.1. Joint Ventures
       3.2. Mergers and Acquisitions
       3.3. Licensing and Partnership
       3.4. Technology Collaborations
       3.5. Strategic Divestments
      4. Market Entry Strategies
      5. Case Studies
    
• 7.   Global Clinical Trial Materials and Supplies Market, By Services Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Logistics and Distribution
      2. Manufacturing and Packaging
       2.1. IMPs and INDs
       2.2. Placebos
       2.3. Assays and Testkits
       2.4. Others
      3. Documentation
      4. Quantitative Clinical Development
      5. Clinical Operations

• 8.   Global Clinical Trial Materials and Supplies Market, By Clinical Trial Type Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Therapeutic and Prevention
       1.1. Vaccines
       1.2. Drug Discovery and Development
       1.3. Therapeutic Devices
       1.4. Biosimilars
       1.5. Therapeutic Assays
       1.6. Therapeutic Procedures
      2. Diagnostics
       2.1. Diagnostic Assay
       2.2.Diagnostic Devices

• 9.   Global Clinical Trial Materials and Supplies Market, By Phase Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Phase 3
      2. Phase 2
      3. Phase 1

• 10.   Global Clinical Trial Materials and Supplies Market, By Medical Specialty Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Oncology
      2. CNS and Mental Disorders
      3. Diabetes
      4. Cardiovascular Diseases
      5. Dermatology
      6. Respiratory Diseases
      7. Blood Disorders
      8. Gastrointestinal Diseases
      9. Infectious Diseases
      10. Ophthalmology
      11. Rare Diseases

• 11.   Global Clinical Trial Materials and Supplies Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Pharmaceuticals and Biologics
      2. Contract Research Organization
      3. Medical Device Companies

• 12.   North America Clinical Trial Materials and Supplies Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. U.S.A
       2.2. Canada
       2.3. Mexico
      3. Market Size (USD Million) Forecast for North America 2023-2031

• 13.   Latin America Clinical Trial Materials and Supplies Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Brazil
       2.2. Venezuela
       2.3. Argentina
       2.4. Rest of Latin America
      3. Market Size (USD Million) Forecast for Latin America 2023-2031

• 14.   Europe Clinical Trial Materials and Supplies Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Germany
       2.2. U.K
       2.3. France
       2.4. Italy
       2.5. Spain
       2.6. Russia
       2.7. Poland
       2.8. Rest of Europe
      3. Market Size (USD Million) Forecast for Europe 2023-2031

• 15.   Asia Pacific Clinical Trial Materials and Supplies Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Japan
       2.2. China
       2.3. India
       2.4. Australia and New Zealand
       2.5. ASEAN
       2.6. Rest of Asia Pacific
      3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

• 16.   Middle East and Africa Clinical Trial Materials and Supplies Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. GCC
       2.2. Israel
       2.3. South Africa
       2.4. Rest of MEA
      3. Market Size (USD Million) Forecast for MEA 2023-2031

• 17.   Market Share Analysis and Competitive Landscape
  •   1. Global Landscape - Key Players, Revenue and Presence
      2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
      3. Global Emerging Companies
      4. North America - Market Share Analysis and Key Regional Players
      5. Europe - Market Share Analysis and Key Regional Players
      6. Asia Pacific - Market Share Analysis and Key Regional Players
      7. Global Key Player - Growth Matrix
    
• 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

  •   1. Thermo-Fisher Scientific Inc.
       1.1. Company Overview
       1.2. Product Portfolio
       1.3. SWOT Analysis
       1.4. Financial Overview
       1.5. Strategic Overview
      2. Capsugel Inc.
       2.1. Company Overview
       2.2. Product Portfolio
       2.3. SWOT Analysis
       2.4. Financial Overview
       2.5. Strategic Overview
      3. Eurofins Scientific Inc.
       3.1. Company Overview
       3.2. Product Portfolio
       3.3. SWOT Analysis
       3.4. Financial Overview
       3.5. Strategic Overview
      4. Intertek Group Plc
       4.1. Company Overview
       4.2. Product Portfolio
       4.3. SWOT Analysis
       4.4. Financial Overview
       4.5. Strategic Overview
      5. Catalent Inc.
       5.1. Company Overview
       5.2. Product Portfolio
       5.3. SWOT Analysis
       5.4. Financial Overview
       5.5. Strategic Overview
      6. Bilcare Inc.
       6.1. Company Overview
       6.2. Product Portfolio
       6.3. SWOT Analysis
       6.4. Financial Overview
       6.5. Strategic Overview
      7. Avomeen Analytical Services Inc.
       7.1. Company Overview
       7.2. Product Portfolio
       7.3. SWOT Analysis
       7.4. Financial Overview
       7.5. Strategic Overview
      8. Recipharma A.B.
       8.1. Company Overview
       8.2. Product Portfolio
       8.3. SWOT Analysis
       8.4. Financial Overview
       8.5. Strategic Overview
      9. Biocair International Ltd.
       9.1. Company Overview
       9.2. Product Portfolio
       9.3. SWOT Analysis
       9.4. Financial Overview
       9.5. Strategic Overview
      10. Mayne Pharma Group Ltd.
       10.1. Company Overview
       10.2. Product Portfolio
       10.3. SWOT Analysis
       10.4. Financial Overview
       10.5. Strategic Overview
      11. Almac Group Ltd.
       11.1. Company Overview
       11.2. Product Portfolio
       11.3. SWOT Analysis
       11.4. Financial Overview
       11.5. Strategic Overview

• 19.   Pre and Post COVID-19 Impact
  •   1. Positive influence on the healthcare industry
      2. The financial disruption of the manufacturing sector
      3. Impact of COVID-19 on emerging companies
      4. Significant mandates in the healthcare regulations initiated by administrations
      5. The overall economic slowdown of the developing and developed nations
    
• 20.   FutureWise SME Key Takeaway Points for Client